Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder

Abstract

Our results indicate a therapeutic window exists, which suggests that therapeutic drug monitoring of risperidone might increase safety and effectiveness in children and adolescents with ASD and behavioural problems.